Nuclear Medicine is arguably the most “futuristic” branch of medical imaging. While a standard X-ray or CT scan shows us what a body looks like, Nuclear Medicine shows us how a body is functioning. It is the intersection of high-level physics, complex chemistry, and patient care.
Below is the exam paper download link
Past Paper On Nuclear Medicine For Revision
Above is the exam paper download link
However, let’s be honest: trying to wrap your head around half-lives, photon attenuation, and the specific biodistribution of Technetium-99m can make anyone’s brain feel a bit “unstable.” The sheer volume of technical data is enough to overwhelm even the most dedicated student. The secret to passing? You have to stop reading and start doing.
Testing your knowledge against real-world exam questions is the only way to ensure that your theoretical understanding translates into clinical competence.
[Download the Nuclear Medicine Revision Past Paper PDF Here]
Nuclear Medicine Q&A: The Revision Essentials
To help you get into the “Gamma” mindset, we’ve broken down some of the most common concepts that appear on certification and final exams.
1. What makes Technetium-99m ($^{99m}Tc$) the “Workhorse” of Nuclear Medicine?
If there is one isotope you must know inside and out, it’s this one.
-
The Reason: It has an ideal physical half-life of approximately 6 hours—long enough to perform a scan, but short enough to minimize the patient’s radiation dose.
-
The Energy: It emits gamma rays at $140 \text{ keV}$, which is the “sweet spot” for modern Gamma Camera detectors.
2. How does a PET Scan differ from a SPECT Scan?
This is a classic comparison question.
-
SPECT (Single Photon Emission Computed Tomography): Uses isotopes that emit a single gamma photon (like $^{99m}Tc$ or $^{123}I$).
-
PET (Positron Emission Tomography): Uses positron-emitting isotopes (like $^{18}F$). When a positron meets an electron, they annihilate, sending two photons in exactly opposite directions. The scanner detects these “coincidence events” to create a much higher-resolution image.
3. What is “ALARA” and why is it the Golden Rule?
ALARA stands for As Low As Reasonably Achievable. In the lab, this means using three specific variables to protect yourself and the patient:
-
Time: Minimize the time spent near the source.
-
Distance: The Inverse Square Law is your friend—doubling your distance from the source quarters your exposure.
-
Shielding: Using lead or tungsten to block or attenuate radiation.
4. Can you explain the “Radiochemical Purity” test?
Before a radiopharmaceutical is injected, we must ensure the isotope is actually bound to the drug. If you are injecting a “Bone Scan” agent but the Technetium is “free” (unbound), it will just go to the thyroid and stomach, giving you a useless image and unnecessary radiation to the patient. We use Thin Layer Chromatography (TLC) to verify this purity.
5. What is the role of the “Photomultiplier Tube” (PMT) in a Gamma Camera?
The PMT is the translator. When a gamma ray hits the sodium iodide crystal, it creates a tiny flash of light (scintillation). The PMT takes that weak flash of light and converts it into an electrical signal that a computer can turn into an image.
Pro-Tips for Dominating Your Nuclear Medicine Exam
-
Master the Math: You will be asked to calculate decaying activity. Practice using the formula $A = A_0 \cdot e^{-\lambda t}$ until it becomes second nature.
-
Understand the “Cold” and “Hot” Spots: In Systematic Nuclear Medicine, know which diseases appear “darker” (increased uptake) versus “lighter.” For example, a “cold” nodule in a thyroid scan is more statistically likely to be malignant than a “hot” one.
-
Use the Past Paper as a Diagnostic: Take the test first. Don’t look at the answers. Mark the questions you got wrong, and then spend 80% of your remaining study time on those specific chapters.
Ready to Power Up Your Prep?
The world of atoms and isotopes is fascinating, but it’s also demanding. Don’t leave your results to chance. Our comprehensive past paper covers everything from instrumentation and radiopharmacy to clinical applications in oncology and cardiology.
